Radiation Concurrent With Gemcitabine for Locally Advanced Head and Neck Cancer: A Phase I Trial and Intracellular Drug Incorporation Study
Avraham Eisbruch(University of Michigan–Ann Arbor), Theodore S. Lawrence(University of Michigan), Laura A. Dawson(Princess Margaret Cancer Centre), Carol R. Bradford(The Ohio State University), Norman D. Hogikyan(Michigan Medicine), Gregory T. Wolf(University of Michigan), Susan G. Urba(University of Michigan), Douglass B. Chepeha(VA Center for Clinical Management Research), Donna S. Shewach(VA Center for Clinical Management Research), Jeffrey E. Terrell(University of Michigan), J. Fred Littles(VA Center for Clinical Management Research), Theodore N. Teknos(University of Michigan), Lawrence J. Marentette(VA Center for Clinical Management Research)
Cited by 146
Related Papers
Validation of an instrument to measure voice-related quality of life (V-RQOL)
|Journal of Voice|1999|1.1k
Sequential Phase I and II Trials of Stereotactic Body Radiotherapy for Locally Advanced Hepatocellular Carcinoma
|Journal of Clinical Oncology|2013|841
Phase I Study of Individualized Stereotactic Body Radiotherapy for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
|Journal of Clinical Oncology|2008|597
Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer
|International Journal of Radiation Oncology*Biology*Physics|2002|508
American Society of Clinical Oncology Clinical Practice Guideline for the Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer
|Journal of Clinical Oncology|2006|504